• Issue

    Cancer Communications: Volume 43, Issue 8

    i, 861-959
    August 2023
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

FEATURED COVER

Open Access

Cover Image, Volume 43, Issue 6

Zhimin Ma,  Jun Lv,  Meng Zhu,  Canqing Yu,  Hongxia Ma,  Guangfu Jin,  Yu Guo,  Zheng Bian,  Ling Yang,  Yiping Chen,  Zhengming Chen,  Zhibin Hu,  Liming Li,  Hongbing Shen, 
  • Page: i
  • First Published: 02 August 2023
Cover Image, Volume 43, Issue 6 Volume 43 Issue 8, 2023

The cover image is based on the Original Article Lung cancer risk score for ever and never smokers in China by Zhimin Ma et al., https://doi.org/10.1002/cac2.12463.

ISSUE INFORMATION

Open Access

Issue Information

  • Pages: 861-862
  • First Published: 02 August 2023

ORIGINAL ARTICLES

Open Access

Differential risk of 23 site-specific incident cancers and cancer-related mortality among patients with metabolic dysfunction-associated fatty liver disease: a population-based cohort study with 9.7 million Korean subjects

Goh Eun Chung,  Su Jong Yu,  Jeong-Ju Yoo,  Yuri Cho,  Kyu-na Lee,  Dong Wook Shin,  Yoon Jun Kim,  Jung-Hwan Yoon,  Kyungdo Han,  Eun Ju Cho, 
  • Pages: 863-876
  • First Published: 19 June 2023
Open Access

Lung cancer risk score for ever and never smokers in China

Zhimin Ma,  Jun Lv,  Meng Zhu,  Canqing Yu,  Hongxia Ma,  Guangfu Jin,  Yu Guo,  Zheng Bian,  Ling Yang,  Yiping Chen,  Zhengming Chen,  Zhibin Hu,  Liming Li,  Hongbing Shen, 
  • Pages: 877-895
  • First Published: 06 July 2023
Open Access

Positron emission tomography-adapted therapy in low-risk diffuse large B-cell lymphoma: results of a randomized, phase III, non-inferiority trial

Qing Shi,  Yang He,  Hong-Mei Yi,  Rong-Ji Mu,  Xu-Feng Jiang,  Di Fu,  Lei Dong,  Wei Qin,  Peng-Peng Xu,  Shu Cheng,  Qi Song,  Sai-Juan Chen,  Li Wang,  Wei-Li Zhao, 
  • Pages: 896-908
  • First Published: 04 July 2023
Open Access

Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer

Xingbin Hu,  Zhenfeng Ma,  Beibei Xu,  Shulong Li,  Zhiqi Yao,  Bishan Liang,  Jiao Wang,  Wangjun Liao,  Li Lin,  Chunling Wang,  Siting Zheng,  Qijing Wu,  Qiong Huang,  Le Yu,  Fenghua Wang,  Min Shi, 
  • Pages: 909-937
  • First Published: 11 July 2023

RESEARCH HIGHLIGHT

Open Access

The MonarchE trial: improving the clinical outcome in HR+/HER2− early breast cancer: recent results and next steps

François Bertucci,  Pascal Finetti,  Emilie Mamessier,  Alexandre De Nonneville, 
  • Pages: 938-942
  • First Published: 18 July 2023

LETTERS TO THE EDITOR

Open Access

Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2-negative breast cancer

François Bertucci,  Alexandre De Nonneville,  Pascal Finetti,  Emilie Mamessier, 
  • Pages: 943-946
  • First Published: 06 June 2023
Open Access

A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment

Tobias Niedermaier,  Elizabeth Alwers,  Xuechen Chen,  Thomas Heisser,  Michael Hoffmeister,  Hermann Brenner, 
  • Pages: 947-950
  • First Published: 04 June 2023
Open Access

Single-cell transcriptomic analysis uncovers intratumoral heterogeneity and drug-tolerant persister in ALK-rearranged lung adenocarcinoma

Hoi-Hin Kwok,  Huiyu Li,  Jiashuang Yang,  Junyang Deng,  Nerissa Chui-Mei Lee,  Timmy Wing-Kuk Au,  Alva Ko-Yung Sit,  Michael Kuan-Yew Hsin,  Stephanie Kwai-Yee Ma,  Lydia Wai-Ting Cheung,  Luc Girard,  Junya Fujimoto,  Ignacio Ivan Wistuba,  Boning Gao,  John Dorrance Minna,  David Chi-Leung Lam, 
  • Pages: 951-955
  • First Published: 04 June 2023
Open Access

Enhanced selection of people for lung cancer screening using AHRR (cg05575921) or F2RL3 (cg03636183) methylation as biological markers of smoking exposure

Megha Bhardwaj,  Ben Schöttker,  Bernd Holleczek,  Hermann Brenner, 
  • Pages: 956-959
  • First Published: 06 June 2023